Gene · 23064
Papers1,471
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,471
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Molecular mechanisms and pathways in cerebellar function. | Front Mol Neurosci | 2023 | 37575965 | PubTator, text mining | PubMed |
| The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders. | Front Immunol | 2023 | 37575227 | PubTator, text mining | PubMed |
| Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy. | Cells | 2023 | 37566027 | PubTator, text mining | PubMed |
| Proteomic profiling of the brain from the wobbler mouse model of amyotrophic lateral sclerosis reveals elevated levels of the astrogliosis marker glial fibrillary acidic protein. | Eur J Transl Myol | 2023 | 37565261 | PubTator, text mining | PubMed |
| Low T-cell reactivity to TDP-43 peptides in ALS. | Front Immunol | 2023 | 37545536 | PubTator, text mining | PubMed |
| Genetic Investigation of Consanguineous Pakistani Families Segregating Rare Spinocerebellar Disorders. | Genes (Basel) | 2023 | 37510308 | PubTator, text mining | PubMed |
| R-loop landscapes in the developing human brain are linked to neural differentiation and cell-type specific transcription. | bioRxiv | 2023 | 37503149 | PubTator, text mining | PubMed |
| Thirty-Year Follow-Up of Early Onset Amyotrophic Lateral Sclerosis with a Pathogenic Variant in SPTLC1. | Case Rep Neurol | 2023 | 37497262 | PubTator, text mining | PubMed |
| Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation. | Front Immunol | 2023 | 37483631 | PubTator, text mining | PubMed |
| Widespread dysregulation of mRNA splicing implicates RNA processing in the development and progression of Huntington's disease. | EBioMedicine | 2023 | 37481821 | PubTator, text mining | PubMed |
| Different SWI/SNF complexes coordinately promote R-loop- and RAD52-dependent transcription-coupled homologous recombination. | Nucleic Acids Res | 2023 | 37470997 | PubTator, text mining | PubMed |
| Phenotype Presentation and Molecular Diagnostic Yield in Non-5q Spinal Muscular Atrophy. | Neurol Genet | 2023 | 37470033 | PubTator, text mining | PubMed |
| MEF2A suppresses stress responses that trigger DDX41-dependent IFN production. | Cell Rep | 2023 | 37467105 | PubTator, text mining | PubMed |
| The platelet transcriptome and proteome in Alzheimer's disease and aging: an exploratory cross-sectional study. | Front Mol Biosci | 2023 | 37457829 | PubTator, text mining | PubMed |
| Loss of PML nuclear bodies in familial amyotrophic lateral sclerosis-frontotemporal dementia. | Cell Death Discov | 2023 | 37454169 | PubTator, text mining | PubMed |
| The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches. | Cancers (Basel) | 2023 | 37444417 | PubTator, text mining | PubMed |
| Glc7/PP1 dephosphorylates histone H3T11 to regulate autophagy and telomere silencing in response to nutrient availability. | Cell Discov | 2023 | 37433812 | PubTator, text mining | PubMed |
| Homozygous mutation in CSF1R causes brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS). | Bioimpacts | 2023 | 37431483 | PubTator, text mining | PubMed |
| Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives. | Iran J Basic Med Sci | 2023 | 37427325 | PubTator, text mining | PubMed |
| Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder. | Biomedicines | 2023 | 37371694 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23064/papers?page=8